Xendo, Sofus Regulatory Affairs, and SOLUTIONS in Health are now ProPharma Group. Learn more.

Michael Farah

Michael Farah has been involved in principal investing and investment banking since 2001. Prior to Linden, he was a Vice President at Metalmark Capital where he focused on healthcare investing. Mr. Farah began his career at UBS Investment Bank where he focused on M&A advisory and capital raising transactions for the healthcare sector and also spent three years with Summit Partners as a private equity associate.

Mr. Farah holds a Bachelor of Arts in Finance, with honors, from Carnegie Mellon University and an MBA from Harvard Business School.

Company Blog

February 14, 2019
Local Person for Pharmacovigilance
Points to consider for Local Person for Pharmacovigilance (LPPV) requirements in different European countries. Read More
January 28, 2019
ProPharma Group Acquires The Weinberg Group
ProPharma Group, a leading provider of compliance services, continues to expand its global presence,… Read More
January 8, 2019
Innocent Until Proven Guilty: Hypothesis Test
If you always make the right decision, this article is not for you. Learn… Read More
More Articles

UPCOMING Events

March 18, 2019
DIA Medical Affairs and Scientific Communications
DIA’s Medical Affairs and Scientific Communications Forum is designed for medical affairs professionals, b... Read More
March 25, 2019
BIO-Europe Spring
Visit ProPharma Group at the BIO-Europe Spring event in Vienna, Austria! Connect with the right partners and b... Read More
All Events
Contact Us